Yanan S. Jiang
Zhengzhou, 450000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Humanized CD70-targeted CAR-T cells with reduced fratricide demonstrate potent antitumor activity against AML and RCC.
Journal: International immunopharmacology
Published: May 08, 2026
Targeting SRSF6 to Enhance Cisplatin Sensitivity by Modulating Redox Balance via NFE2L1 exon 4 Splicing in ESCC.
Journal: International journal of biological sciences
Published: January 16, 2026
The emerging roles of alternative splicing in modulating tumor immune responses and immunotherapies.
The emerging roles of alternative splicing in modulating tumor immune responses and immunotherapies.
Journal: Cell death and differentiation
Published: November 17, 2025
Fc-Engineered B7-H3 Antibody with Prolonged Serum Half-Life for Enhanced Cancer Therapy.
Journal: Molecular pharmaceutics
Published: October 31, 2025
PDIA6 promotes the cell proliferation of ESCC by enhancing the disulfide bond formation in TRAF4.
Journal: Cellular & molecular biology letters
Published: September 08, 2025
CAR T cells targeting B7H3 demonstrate potent preclinical activity against AML and ESCC.
Journal: International immunopharmacology
Published: June 04, 2025
LncRNA-Protein Interactions: A Key to Deciphering LncRNA Mechanisms.
Journal: Biomolecules
Published: April 24, 2025
CERS6 promotes esophageal squamous cell carcinoma proliferation by increasing the stability of RPN1.
CERS6 promotes esophageal squamous cell carcinoma proliferation by increasing the stability of RPN1.
Journal: Cell death discovery
Published: March 26, 2025
Global landscape of protein-coding and long non-coding RNA alternative splicing and regulation in the human esophageal squamous cell carcinoma.
Journal: Cancer cell international
Published: February 06, 2025
Inflammation in cancer: therapeutic opportunities from new insights.
Journal: Molecular cancer
Published: October 10, 2024
Atg5-deficient mesenchymal stem cells protect against non-alcoholic fatty liver by accelerating hepatocyte growth factor secretion.
Journal: Cell communication and signaling : CCS
Published: September 02, 2024
Last Updated: 09/26/2026